Loading clinical trials...
Loading clinical trials...
Phase 4 Study to Characterize and Evaluate Markers of Chemoresistance in Patients With Metastatic Colorectal Cancer
Conditions
Interventions
capecitabine
fluorouracil
+5 more
Locations
1
France
Centre Hospital Regional Universitaire de Limoges
Limoges, France
Start Date
March 1, 2005
Primary Completion Date
May 1, 2011
Last Updated
May 16, 2011
NCT06696768
NCT04704661
NCT05489211
NCT04657068
NCT06625775
NCT06607458
Lead Sponsor
Centre Hospital Regional Universitaire de Limoges
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions